Robert Lanza

{{short description|American medical doctor and scientist}}

{{pp-pc|small=yes}}

{{Use dmy dates|date=January 2023}}

{{Infobox scientist

| name = Robert P. Lanza

| image = Robert Lanza in laboratory (cropped).JPG{{!}}border

| caption = Lanza in 2009

| birth_name = Robert Lanza

| birth_date = {{birth date and age|1956|2|11|df=yes}}

| birth_place = Boston, Massachusetts, U.S.

| death_date =

| death_place =

| citizenship =

| nationality = American

| workplaces = Astellas Institute for Regenerative Medicine, Wake Forest University School of Medicine

| alma_mater = University of Pennsylvania

| doctoral_advisor =

| academic_advisors =

| doctoral_students =

| notable_students =

| known_for = Stem cell biology, cloning,
tissue engineering, biocentric universe

| author_abbrev_bot =

| author_abbrev_zoo =

| awards =

| religion =

| signature =

| footnotes =

}}

Robert Lanza (born 11 February 1956 in Boston, Massachusetts) is an American medical doctor and scientist, currently Head of Astellas Global Regenerative Medicine,{{Cite web |last=Herper |first=Matthew |title=A Biotech Provocateur Takes On Physics |url=https://www.forbes.com/2007/03/09/lanza-theories-physics-biotech-oped-cx_mh_0309lanza.html |access-date=26 March 2021 |website=Forbes |language=en}}{{cite news |url=https://www.bostonglobe.com/business/2016/02/22/ocata-chief-scientific-officer-join-astellas-head-global-regenerative-medicine/pptDFkpb3d6ei0b8x5PlKN/story.html |title= Ocata's chief scientific officer to join new parent after acquisition |newspaper= Boston Globe |access-date=24 February 2016}} and Chief Scientific Officer of the Astellas Institute for Regenerative Medicine. He is an Adjunct Professor at Wake Forest University School of Medicine.{{Cite web |url=https://school.wakehealth.edu/research/institutes-and-centers/wake-forest-institute-for-regenerative-medicine/adjunct-faculty |title= Wake Forest University School of Medicine Adjunct Faculty |website=Wake Forest University: School of Medicine |access-date=1 October 2022}}

Early life and education

Lanza was born in Boston, Massachusetts, and grew up south of there, in Stoughton, Massachusetts.

Lanza "altered the genetics of chickens in his basement", and came to the attention of Harvard Medical School researchers when he appeared at the university with his results.

Jonas Salk, B. F. Skinner, and Christiaan Barnard mentored Lanza over the next ten years.{{Cite journal |last=Fischer |first=Joannie |title=The First Clone |journal=U.S. News & World Report |pages=50–4, 57–8, 60–3 |date=25 November 2001 |pmid=11765373 |url=https://www.usnews.com/usnews/culture/articles/011203/archive_019784_4.htm |access-date=20 August 2008 |url-status=dead |archive-url=https://web.archive.org/web/20080826081744/http://www.usnews.com/usnews/culture/articles/011203/archive_019784_4.htm |archive-date=26 August 2008 |volume=131 |issue=23}} Lanza attended the University of Pennsylvania, receiving BA and MD degrees. There, he was a Benjamin Franklin Scholar and a University Scholar. Lanza was also a Fulbright Scholar. He currently resides in Clinton, Massachusetts.{{citation needed|date=March 2021}}

Career

=Stem cell research=

Lanza was part of the team that cloned the world's first early stage human embryos,{{Cite journal |last1=Cibelli |first1=Jose B. |last2=Lanza |first2=Robert P. |last3=West |first3=Michael D. |author3-link=Michael D. West |last4=Ezzell |first4=Carol |title=The First Human Cloned Embryo |journal=Scientific American |pages=44–51 |date=24 November 2001 |volume=286 |issue=1 |doi=10.1038/scientificamerican0102-44 |pmid=11799617 |url=http://www.sciam.com/article.cfm?id=the-first-human-cloned-em |access-date=20 August 2008|url-access=subscription }}{{cite magazine|url=https://www.wired.com/wired/archive/12.01/clones.html |title=Wired 12.01: Seven Days of Creation |magazine=Wired |date=4 January 2009 |access-date=9 August 2009}} as well as the first to successfully generate stem cells from adults using somatic-cell nuclear transfer (therapeutic cloning).{{cite journal |author1=Chung, Young Gie |author2=Jin Hee Eum |author3=Jeoung Eun Lee |author4=Sung Han Shim |author5=Vicken Sepilian |display-authors=1 |title=Human somatic cell nuclear transfer using adult cells |publisher=Cell Press |doi=10.1016/j.stem.2014.03.015 |volume=14 |year=2014 |journal=Cell Stem Cell |issue=6 |pages=777–780 |pmid=24746675|doi-access=free }}{{cite news |url=https://online.wsj.com/news/articles/SB10001424052702303626804579507593658361428 |title=Scientists Make First Embryo Clones From Adults |newspaper=The Wall Street Journal |date=17 April 2014 |access-date=18 April 2014 |first=Gautam |last=Naik}}

Lanza demonstrated that techniques used in preimplantation genetic diagnosis could be used to generate embryonic stem cells without embryonic destruction.{{cite journal |author1=Klimanskaya, Irina |author2=Chung, Young |author3=Becker, Sandy |author4=Lu, Shi-Jiang |author5=Lanza, Robert |display-authors=1 |title=Human embryonic stem cell lines derived from single blastomeres |journal=Nature |doi=10.1038/nature05142 |pmid=16929302 |volume=444 |issue=7118 |pages=481–485 |year=2006 |bibcode=2006Natur.444..481K |s2cid=84792371}}

In 2001, he was also the first to clone an endangered species (a Gaur),{{cite web |url=http://www.sciam.com/article.cfm?articleID=0002AB9E-F4AA-1C72-9B81809EC588EF21 |title=Cloning Noah's Ark: Scientific American |publisher=Scientific American |date=19 November 2000 |access-date=9 August 2009}} and in 2003, he cloned an endangered wild ox (a Banteng){{cite web |url=https://www.npr.org/templates/story/story.php?storyId=1225049 |title=Wild Cows Cloned |publisher=NPR |date=8 April 2003 |access-date=9 August 2009}} from the frozen skin cells of an animal that had died at the San Diego Zoo nearly a quarter-of-a-century earlier.

Lanza and his colleagues were the first to demonstrate that nuclear transplantation could be used to extend the lifespan of certain cells{{cite journal|url=http://www.columbia.edu/itc/biology/pollack/w4065/client_edit/readings/science288_665.pdf |title=Extension of Cell Life-Span and Telomere Length in Animals Cloned from Senescent Somatic Cells |author1=Lanza, Robert P. |author2=Jose B. Cibelli |author3=Catherine Blackwell |author4=Vincent J. Cristofalo |author5=Mary Kay Francis |author6=Gabriela M. Baerlocher |author7=Jennifer Mak |author8=Michael Schertzer |author9=Elizabeth A. Chavez |author10=Nancy Sawyer |author11=Peter M. Lansdorp |author12=Michael D. West |display-authors=1 |journal=Science |date=28 April 2000 |volume=288 |issue=5466 |pages=665–669 |doi=10.1126/science.288.5466.665 |pmid=10784448 |bibcode=2000Sci...288..665L}} and to generate immune-compatible tissues, including the first organ grown in the laboratory from cloned cells.{{cite journal |title=Generation of histocompatible tissues using nuclear transplantation |volume=20 |doi=10.1038/nbt703 |journal=Nature Biotechnology |pages=689–696 |year=2002 |last1=Lanza |first1=Robert P. |issue=7 |pmid=12089553|s2cid=23007326}}

Lanza showed that it is feasible to generate functional oxygen-carrying red blood cells from human embryonic stem cells under conditions suitable for clinical scale-up. The blood cells could potentially serve as a source of "universal" blood.{{cite journal|title=Blood - Biological properties and enucleation of red blood cells from human embryoni |doi=10.1182/blood-2008-05-157198 |pmc=2597123 |publisher=Bloodjournal.hematologylibrary.org |pmid=18713948 |volume=112 |year=2008 |journal=Blood |pages=4475–84 |last1=Lu |first1=SJ |last2=Feng |first2=Q |last3=Park |first3=JS |last4=Vida |first4=L |last5=Lee |first5=BS |last6=Strausbauch |first6=M |last7=Wettstein |first7=PJ |last8=Honig |first8=GR |last9=Lanza |first9=R|issue=12}}{{Cite web|url=http://www.timesonline.co.uk/tol/life_and_style/health/article4567387.ece |title=Transfusion breakthrough as human blood grown from stem cells |date=20 August 2008 |archive-url=https://web.archive.org/web/20081120184302/http://www.timesonline.co.uk/tol/life_and_style/health/article4567387.ece|archive-date=20 November 2008 |url-status=dead |last=Henderson |first=Mark |website=Times Online}}

His team discovered how to generate functional hemangioblasts (a population of "ambulance" cells{{cite news|last=Vergano |first=Dan |url=https://www.usatoday.com/tech/science/discoveries/2007-05-07-ambulance-cells_N.htm |title=Elusive 'ambulance' cells are created - USATODAY.com |website=USA Today |date=8 May 2007 |access-date=9 August 2009}}) from human embryonic stem cells.

In animals, these cells quickly repaired vascular damage, cutting the death rate after a heart attack in half and restoring the blood flow to ischemic limbs that might otherwise have required amputation.{{cite journal |title=Generation of functional hemangioblasts from human embryonic stem cells |volume=4 |issue=6 |doi=10.1038/nmeth1041 |pmid=17486087 |journal=Nature Methods |pages=501–509|pmc=3766360 |year=2007 |last1=Lu |first1=S. J. |last2=Feng |first2=Q. |last3=Caballero |first3=S. |last4=Chen |first4=Y. |last5=Moore |first5=M. A. |last6=Grant |first6=M. B. |last7=Lanza |first7=R.}}

In 2012 Lanza and a team led by Kwang-Soo Kim at Harvard University reported a method for generating induced pluripotent stem (iPS) cells by incubating them with proteins, instead of genetically manipulating the cells to make more of those proteins.{{cite magazine |url=http://www.time.com/time/health/article/0,8599,1901512,00.html |archive-url=https://web.archive.org/web/20090531082212/http://www.time.com/time/health/article/0,8599,1901512,00.html |url-status=dead |archive-date=31 May 2009 |title= Researchers Hail Stem Cells Safe for Human Use |magazine=Time |date=28 May 2009 |access-date=30 August 2009 |first=Alice |last=Park}}{{cite news |url=https://www.wsj.com/articles/SB10001424127887324296604578177420241514666 |title=Stem-Cell Trial Without Embryo Destruction |newspaper=Wall Street Journal |date=13 December 2012 |access-date=14 January 2013 |first=Jonathan |last=Rockoff}}{{cite journal |title=Cell Stem Cell - Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins |doi=10.1016/j.stem.2009.05.005 |volume=4 |year=2009 |journal=Cell Stem Cell |pages=472–476 |last1=Kim |first1=Dohoon |issue=6 |pmid=19481515 |pmc=2705327}}

=Clinical trials for blindness=

Lanza's team at Advanced Cell Technology were able to generate retinal pigmented epithelium cells from stem cells, and subsequent studies found that these cells could restore vision in animal models of macular degeneration.{{cite journal |title=Human Embryonic Stem Cell–Derived Cells Rescue Visual Function in Dystrophic RCS Rats – Cloning Stem Cells |journal=Cloning and Stem Cells |volume=8 |issue=3 |pages=189–99 |publisher=Mary Ann Liebert |date=29 September 2006 |doi=10.1089/clo.2006.8.189 |pmid=17009895 |last1=Lund |first1=R. D. |last2=Wang |first2=S. |last3=Klimanskaya |first3=I. |last4=Holmes |first4=T. |last5=Ramos-Kelsey |first5=R. |last6=Lu |first6=B. |last7=Girman |first7=S. |last8=Bischoff |first8=N. |last9=Sauvé |first9=Y. |last10=Lanza |first10=R. |s2cid=12566730 }}{{cite magazine |url=https://www.wired.com/medtech/genetics/news/2004/09/65070 |title=Stem Cells May Open Some Eyes |magazine=Wired |access-date=30 August 2009 |date=24 September 2004 |url-status=dead |archive-url=https://web.archive.org/web/20090815202318/http://www.wired.com/medtech/genetics/news/2004/09/65070 |archive-date=15 August 2009 }} With this technology, some forms of blindness could potentially be treatable.{{cite news |url=https://www.robertlanza.com/mit-technology-review-two-patients-undergo-stem-cell-blindness-treatment/ |title=Two Patients Undergo Stem-Cell Blindness Treatment |magazine= Technology Review |date=14 July 2011 |access-date=24 May 2020}}

In 2010, ACT received approval from the Food and Drug Administration for clinical trials of a pluripotent stem cell-based treatment for use in people with degenerative eye diseases.{{cite magazine |url=https://healthland.time.com/2010/11/22/fda-approves-second-trial-of-stem-cell-therapy/ |title=FDA Approves Second Trial of Stem-Cell Therapy |magazine=Time |date=22 November 2010 |access-date=7 December 2010}}{{cite news |url=http://content.usatoday.com/communities/sciencefair/post/2010/11/second-human-embryonic-stem-cell-clinical-trial-to-start/1 |title=Second human embryonic stem cell clinical trial to start |newspaper=USA Today |date=22 November 2010 |access-date=7 December 2010}} In 2011 ACT received approval from the Medicines and Healthcare products Regulatory Agency to use its PSC-based cell therapy in the UK; this was the first approval to study a PSC-based treatment in Europe.{{cite news |url=https://www.theguardian.com/science/2011/sep/22/embryonic-stem-cell-trial-blindness? |title= First trial of embryonic stem cell treatment in Europe gets green light |newspaper=The Guardian |date=22 September 2011 |access-date=22 September 2011 |location=London |first=Ian |last=Sample}}{{cite magazine |url=https://healthland.time.com/2011/09/22/first-european-embryonic-stem-cell-trial-gets-green-light/ |title=First European Embryonic Stem Cell Trial Gets Green Light |magazine=Time |date=22 September 2011 |access-date=22 September 2011}} The first person received the embryonic stem cell treatment in the UK in 2012.{{cite news |url= https://www.theguardian.com/science/2012/jun/04/stem-cell-first-human-trials | title= Stem cell scientists take hope from first human trials but see long road ahead | newspaper= The Guardian |date=4 June 2012 |access-date=11 June 2012 |location=London |first=Sarah |last=Boseley}}

The results of the first two clinical trials were published in the Lancet in 2012,{{cite journal |last1=Schwartz |first1=SD |last2=Hubschman |first2=JP |last3=Heilwell |first3=G |last4=Franco-Cardenas |first4=V |last5=Pan |first5=CK |last6=Ostrick |first6=RM |last7=Mickunas |first7=E |last8=Gay |first8=R |last9=Klimanskaya |first9=I |last10=Lanza |first10=R |title=Embryonic stem cell trials for macular degeneration: a preliminary report |journal=Lancet |date=25 February 2012 |volume=379 |issue=9817 |pages=713–20 |doi=10.1016/S0140-6736(12)60028-2 |pmid=22281388|s2cid=2230787 |display-authors=1}} {{open access}} with a follow-up paper in 2014,{{cite journal|title=Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy |date=15 October 2014 |pmid=25458728 | doi=10.1016/S0140-6736(14)61376-3 |volume=385 |issue=9967 |journal=Lancet |pages=509–16 |last1=Schwartz |first1=SD |last2=Regillo |first2=CD |last3=Lam |first3=BL |last4=Eliott |first4=D |last5=Rosenfeld |first5=PJ |last6=Gregori |first6=NZ |last7=Hubschman |first7=JP |last8=Davis |first8=JL |last9=Heilwell |first9=G |last10=Spirn |first10=M |last11=Maguire |first11=J |last12=Gay |first12=R |last13=Bateman |first13=J |last14=Ostrick |first14=RM |last15=Morris |first15=D |last16=Vincent |first16=M |last17=Anglade |first17=E |last18=Del Priore |first18=LV |last19=Lanza |first19=R |s2cid=85799 |display-authors=1}} which provided the first published reports of the long-term safety and possible biologic activity of pluripotent stem cell progeny into humans.{{cite news |url= https://time.com/3507094/stem-cells-eyesight/ |title= Stem Cells Allow Nearly Blind Patients to See |magazine=Time |date=14 October 2014 |access-date=24 May 2020}}

=[[Science policy|Science policy activism]]=

In 2001, Lanza initiated a letter to US president G.W.Bush, urging him to not block the first flow of federal dollars for research on human embryo cells. The letter was signed by 80 Nobel laureates from various areas of science and send to the White House by FAX, three weeks before a deadline to apply for NIH stem cell research grants.{{cite news |url= https://www.washingtonpost.com/archive/politics/2001/02/22/nobel-laureates-back-stem-cell-research/fb59cccc-84d8-420d-ae3a-72dd83b75d3f/ |title= Nobel Laureates Back Stem Cell Research |magazine=The Washington Post |date=22 February 2001 |access-date=31 December 2023}} This was in view of the intention by the Health and Human Services Secretary to revise the decision of the Clinton administration to generously fund stem cell research.

=Biocentrism=

In 2007 Lanza's article "A New Theory of the Universe" appeared in The American Scholar.{{cite magazine |url= http://www.theamericanscholar.org/a-new-theory-of-the-universe/ |title= A New Theory of the Universe: Biocentrism builds on quantum physics by putting life into the equation |last=Lanza |first=Robert |date=1 March 2007 |magazine=The American Scholar}} Spring 2007 issue The essay proposed Lanza's idea of a biocentric universe, which places biology above the other sciences.{{cite magazine |author=Aaron Rowe |url=https://www.wired.com/medtech/genetics/news/2007/03/72910 |title=Will Biology Solve the Universe? |magazine=Wired |date=4 January 2009 |access-date=9 August 2009}}{{cite web |url=http://cosmiclog.msnbc.msn.com/archive/2007/03/08/85328.aspx |archive-url=https://web.archive.org/web/20070312054055/http://cosmiclog.msnbc.msn.com/archive/2007/03/08/85328.aspx |url-status=dead |archive-date=12 March 2007 |title=Cosmic Log: Theory of Every-Living-Thing |publisher=Cosmic Log |via=MSNBC |access-date=9 August 2009}}{{cite news |url=http://asp.usatoday.com/community/tags/topic.aspx |title=Robert Lanza - Tag Story Index |publisher=USA Today |date=16 October 2008 |access-date=9 August 2009}} Lanza's book Biocentrism: How Life and Consciousness are the Keys to Understanding the Universe followed in 2009, co-written with Bob Berman.{{Cite book |last1=Lanza |first1=Robert |last2=Berman |first2=Bob |author2-link=Bob Berman |title=Biocentrism: How Life and Consciousness Are the Keys to Understanding the True Nature of the Universe |date=April 14, 2009 |publisher=BenBella Books |isbn=978-1-933771-69-4}}

Lanza's biocentric hypothesis met with a mixed reception.{{Cite news |url=http://cosmiclog.nbcnews.com/_news/2009/06/16/4351357-the-universe-in-your-head |title=The universe in your head |publisher=Cosmic Log |newspaper=NBC News |access-date=14 December 2016}} Nobel laureate in medicine E. Donnall Thomas stated that "Any short statement does not do justice to such a scholarly work. The work is a scholarly consideration of science and philosophy that brings biology into the central role in unifying the whole." Former Arizona State University physicist and antitheist activist Lawrence Krauss stated: "There are no scientific breakthroughs about anything, as far as I can see. It may represent interesting philosophy, but it doesn't look, at first glance, as if it will change anything about science." In USA Today Online, astrophysicist and science writer David Lindley asserted that Lanza's concept was a "...vague, inarticulate metaphor..." and stated that "...I certainly don't see how thinking his way would lead you into any new sort of scientific or philosophical insight. That's all very nice, I would say to Lanza, but now what?"{{cite web |url=http://www.usatoday.com/tech/science/2007-03-09-lanza-response_N.htm |title=Exclusive: Response to Robert Lanza's essay |publisher=USA Today |date=9 March 2007 |access-date=17 August 2009}} Daniel Dennett, a Tufts University philosopher and eliminative materialist, said he did not think the concept meets the standard of a philosophical theory. "It looks like an opposite of a theory, because he doesn't explain how [consciousness] happens at all. He's stopping where the fun begins."

Lanza subsequently published several books that further developed his concept of biocentrism including a 2016 book, Beyond Biocentrism: Rethinking Time, Space, Consciousness, and the Illusion of Death, and a third, The Grand Biocentric Design: How Life Creates Reality, written with Bob Berman and theoretical physicist Matej Pavšič, and published in 2020.{{Cite book |last1=Lanza |first1=Robert |last2=Berman |first2=Bob |author2-link=Bob Berman |title=Beyond Biocentrism: Rethinking Time, Space, Consciousness, and the Illusion of Death |date=May 3, 2016 |publisher=BenBella Books |isbn=978-1942952213}}{{Cite book |last1=Lanza |first1=Robert |last2=Pavšič |first2=Matej |author2-link=Matej Pavšič |title=The Grand Biocentric Design: How Life Creates Reality |date=17 November 2020 |publisher=BenBella Books |isbn=978-1950665402}}

In January 2023, Lanza published a novel exploring biocentrism, Observer with science fiction author Nancy Kress.{{cite web |last=Boyle |first=Alan |author-link=Alan Boyle |url=https://www.geekwire.com/2023/kress-lanza-observer-consciousness-quantum/ |title=Sci-fi author and scientist team up to write a novel about consciousness and quantum weirdness |website=GeekWire |date=January 9, 2023 |access-date=April 15, 2023}} Lanza said in an interview that he wanted "to bring [biocentrism] to life" in a story that would explain that "space, time, and the nature of life and death itself depends on the observer in us."{{cite magazine |last=Picker |first=Lenny |url=https://search.ebscohost.com/login.aspx?direct=true&db=bth&AN=160446798&site=eds-live&scope=site |title=[Q&A]: PW Talks with Robert Lanza and Nancy Kress: I See, Therefore You Are |magazine=Publishers Weekly |date=November 28, 2022 |volume=269 |issue=50 |page=31}} {{subscription required |via=[https://www.ebsco.com EBSCO]'s Business Source Complete}}

Bibliography

;Non-fiction

{{Expand section|date=April 2023}}

  • Biocentrism, How Life and Consciousness are the Keys to Understanding the True Nature of the Universe (2009) – with Bob Berman
  • Beyond Biocentrism, Rethinking Time, Space, Consciousness, and the Illusion of Death (2016) – with Bob Berman
  • The Grand Biocentric Design, How Life Creates Reality (2020) – with Matej Pavšič and Bob Berman

;Novels

Awards and public commentary

Lanza has received numerous awards and other recognition, including:

  • 2006: named "Mass High Tech All Star" at the 11th annual award reception{{cite web |url=https://www.biospace.com/article/releases/-b-dr-robert-lanza-b-receives-2006-all-star-award-for-biotechnology-/ |title=Dr. Robert Lanza Receives 2006 'All Star' Award For Biotechnology |date=24 October 2006 |website=BioSpace |access-date=10 January 2023}}{{cite news |url=http://www.masshightech.com/stories/2009/08/10/weekly2-Robert-Lanza-on-stem-cells-and-access-to-health-care.html |title=Thought Leaders: Robert Lanza on stem cells and access to health care |first=Marc |last=Songini |date=14 August 2009 |publisher=Mass High Tech |url-status=dead |archive-url=https://web.archive.org/web/20090815153233/http://www.masshightech.com/stories/2009/08/10/weekly2-Robert-Lanza-on-stem-cells-and-access-to-health-care.html |archive-date=15 August 2009 |access-date=10 January 2023}}
  • 2010: BioWorld (publication) hailed Lanza as a "stem cell pioneer" and recognized him as one of twenty-eight "movers and shakers" who would shape biotechnology over the next twenty years{{cite news |url=https://www.cnbc.com/2010/05/10/advanced-cell-technologys-chief-scientific-officer-dr-robert-lanza-honored-by-bioworld-magazine-as-leader-who-could-shape-biotech-over-next-20years-dr-lanza-recognized-as-a-stem-cell-pioneer.html |title=Advanced Cell Technology's Chief Scientific Officer Dr. Robert Lanza Honored By BioWorld Magazine As Leader Who Could Shape Biotech Over Next 20 Years Dr. Lanza Recognized as a "Stem Cell Pioneer" |publisher=CNBC |date=10 May 2010 |url-status=live |archive-url=https://web.archive.org/web/20210117191553/https://www.cnbc.com/2010/05/10/advanced-cell-technologys-chief-scientific-officer-dr-robert-lanza-honored-by-bioworld-magazine-as-leader-who-could-shape-biotech-over-next-20years-dr-lanza-recognized-as-a-stem-cell-pioneer.html |archive-date=17 January 2021 |access-date=10 January 2023}}
  • 2010: for research in "translating basic science discoveries into new and better treatments"; won a National Institutes of Health (NIH) Director's Opportunity Award{{cite web |url=http://www.masshightech.com:80/stories/2010/09/20/daily35-Stem-cell-leaders-Lanza-Kim-win-19M-NIH-award.html |title=Stem cell leaders Lanza, Kim win $1.9M NIH award |website=Mass High Tech |date=22 September 2010 |url-status=dead |archive-url=https://web.archive.org/web/20100925203014/http://www.masshightech.com:80/stories/2010/09/20/daily35-Stem-cell-leaders-Lanza-Kim-win-19M-NIH-award.html |archive-date=25 September 2010 |access-date=10 January 2023}}
  • 2013: nominated to receive the Italian Heritage and Culture Committee of the Bronx and Westchester "Il Leone di San Marco Award in Medicine"{{cite web |url=https://www.biospace.com/article/releases/advanced-cell-technology-s-b-dr-robert-lanza-b-to-receive-the-il-leone-di-san-marco-award-in-medicine-/ |title=Advanced Cell Technology's Dr. Robert Lanza to Receive the Il Leone di San Marco Award in Medicine |date=24 September 2013 |website=BioSpace |access-date=10 January 2023}}{{cite news |url=http://trove.nla.gov.au/work/185112045?q&versionId=201577072 |title=ACT's Dr. Robert Lanza to Receive the Il Leone di San Marco Award in Medicine |date=24 September 2013 |website=Trove |url-status=dead |archive-url=https://web.archive.org/web/20160116213357/https://trove.nla.gov.au/work/185112045?q&versionId=201577072 |archive-date=16 January 2016 |access-date=10 January 2023}}
  • 2014: included in the Time magazine Time 100 list of the "100 Most Influential People in the World"{{cite magazine |url=https://time.com/72173/ |title=Time: The 100 Most Influential People - Robert Lanza |magazine=Time |date=23 April 2014 |first=Alice |last=Park |url-status=live |archive-url=https://web.archive.org/web/20140425011354/http://time.com/72173/ |archive-date=25 April 2014 |access-date=10 January 2023}}
  • 2015: included in the Prospect magazine list of the "Top 50 World Thinkers"{{cite news |url=http://www.prospectmagazine.co.uk/philosophy/world-thinkers-2015-robert-lanza |title=World Thinkers 2015: Robert Lanza |website=Prospect |date=16 February 2015 |url-status=live |archive-url=https://web.archive.org/web/20150404185333/https://www.prospectmagazine.co.uk/philosophy/world-thinkers-2015-robert-lanza |archive-date=4 April 2015 |access-date=10 January 2023}}

References

{{reflist|2}}